The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Open accessAbstract
A potent, synthetic cannabinoid was radiolabeled and used to characterize and precisely localize cannabinoid receptors in slide-mounted sections of rat brain and pituitary. Assay conditions for 3H-CP55,940 binding in Tris-HCl buffer with 5% BSA were optimized, association and dissociation rate constants determined, and the equilibrium dissociation constant (Kd) calculated (21 nM by liquid scintillation counting, 5.2 nM by quantitative autoradiography). The results of competition studies, using several synthetic cannabinoids, add to prior data showing enantioselectivity of binding and correlation of in vitro potencies with potencies in biological assays of cannabinoid actions. Inhibition of binding by guanine nucleotides was selective and profound: Nonhydrolyzable analogs of GTP and GDP inhibited binding by greater than 90%, and GMP and the nonhydrolyzable ATP analog showed no inhibition. Autoradiography showed great heterogeneity of binding in patterns of labeling that closely conform to cytoarchitectural and functional domains. Very dense 3H-CP55,940 binding is localized to the basal ganglia (lateral caudate-putamen, globus pallidus, entopeduncular nucleus, substantia nigra pars reticulata), cerebellar molecular layer, innermost layers of the olfactory bulb, and portions of the hippocampal formation (CA3 and dentate gyrus molecular layer). Moderately dense binding is found throughout the remaining forebrain. Sparse binding characterizes the brain stem and spinal cord. Densitometry confirmed the quantitative heterogeneity of cannabinoid receptors (10 nM 3H-CP55,940 binding ranged in density from 6.3 pmol/mg protein in the substantia nigra pars reticulata to 0.15 pmol/mg protein in the anterior lobe of the pituitary). The results suggest that the presently characterized cannabinoid receptor mediates physiological and behavioral effects of natural and synthetic cannabinoids, because it is strongly coupled to guanine nucleotide regulatory proteins and is discretely localized to cortical, basal ganglia, and cerebellar structures involved with cognition and movement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1 receptors are localized to the central nervous system (CNS) and the periphery. CB1 receptors are found in sites associated with pain processing, including the periaqueductal gray (PAG),8 rostral ventromedial medulla (RVM),8 thalamus,9 dorsal root ganglia (DRG),10 amygdala,8 and cortex8.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,405
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Self-citationIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Self-citationThe organization of the projection from the cerebral cortex to the striatum in the rat
McGeorge, A. J., & Faull, R. L. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90128-0 · Cited by 1,360
Baserga, R. (1967) · JAMA · doi:10.1001/jama.1967.03130250093034 · Cited by 1,146
Hypoplasia of cerebellar vermal lobules VI and VII in autism
Courchesne, E., Yeung-Courchesne, R., Hesselink, J. R., & Jernigan, T. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182102 · Cited by 1,058
Rogers, A. W. (1967) · Medical Entomology and Zoology · Cited by 1,026
Kelley, A. E., Domesick, V. B., & Nauta, W. J. H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90067-7 · Cited by 888
Research works printed but not linked: 3
- Harris LS, Dewey WL, Razdan RK (1977) Cannabis. Its chemistry, pharmacology, and toxicology. In: Handbook of experimental phar- macology (Martin WR, ed), pp 37 l-%29. New York: Springer.
- Margulies JE, Hammer RP (1991) THC alters cerebral metabolism in limbic and cortical regions in a biphasic, dose-dependent manner. Ale Drug Res, in press.
- Pertwee RG (1985) Cannabis. In: Psychopharmacology 2, Pt 1: Pre- clinical psychopharmacology (Grahame-Smith DG, Cowan PJ, eds), pp 364-39 1. Amsterdam: Elsevier.
Cited by
Sorted by citations
Items 701–800 of 1,009
THE CANNABINOID AGONIST HU 210 MODIFIES RAT BEHAVIOURAL RESPONSES TO NOVELTY AND STRESS
Giuliani, D., FERRARI, F., & Ottani, A. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0560 · Cited by 67
Carta, G., Nava, F. A., & GESSA, G. L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00738-0 · Cited by 67
ROLE OF THE ENDOCANNABINOID SYSTEM IN THE DEVELOPMENT OF TOLERANCE TO ALCOHOL
Basavarajappa, B. S., & Hungund, B. L. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh111 · Cited by 67
Finn, D. P., Beckett, S. R. G., Richardson, D., Kendall, D. A., Marsden, C. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03509.x · Cited by 66
Mendiguren, A., Aostri, E., & Pineda, J. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.029 · Cited by 68
Lisboa, S. F. D. S., Resstel, L. B. M., de Aguiar, D. C., & Guimarães, F. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.032 · Cited by 67
Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors
Umathe, S. N., Manna, S. S. S., Utturwar, K. S., & Jain, N. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.020 · Cited by 69
What can we learn about schizophrenia from studying the human model, drug‐induced psychosis?
Murray, R. M., Paparelli, A., Morrison, P. D., Marconi, A., & Forti, M. D. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32177 · Cited by 72
Margulies, J. E., & Hammer, R. P. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90281-t · Cited by 66
Basic neuroanatomy and neuropharmacology of cannabinoids
Breivogel, C. S., & Sim‐Selley, L. J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782760 · Cited by 71
Linsenbardt, D. N., & Boehm, S. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.007 · Cited by 66
Han, X., He, Y., Bi, G., Zhang, H., Song, R., Liu, Q., Egan, J. M., Gardner, E. L., Li, J., & Xi, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-12399-z · Cited by 66
Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain.
Martin, B. R., & Wiley, J. L. (2004) · PubMed · Cited by 65
Endocannabinoid system and pain: an introduction
Burston, J. J., & Woodhams, S. G. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003650 · Cited by 67
Distribution of CB2 cannabinoid receptor in adult rat retina
López, E. M., Tagliaferro, P. A., Onaivi, E. S., & López‐Costa, J. J. (2010) · Synapse · doi:10.1002/syn.20856 · Cited by 65
Cannabinoid Modulation of Neuroinflammatory Disorders
Saito, V. M., Rezende, R. M., & Teixeira, A. L. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604515 · Cited by 67
Regulation of the Hippocampal Network by VGLUT3-Positive CCK- GABAergic Basket Cells
Fasano, C., Rocchetti, J., Pietrajtis, K., Zander, J.-F., Manseau, F., Sakae, D. Y., Marcus-Sells, M., Ramet, L., Morel, L. J., Carrel, D., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00140 · Cited by 67
García‐Gutiérrez, M. S., Navarrete, F., Navarro, G., Reyes‐Resina, I., Franco, R., Lanciego, J. L., Giner, S., & Manzanares, J. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0610-y · Cited by 67
Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro
Jennings, E. A., Vaughan, C. W., & Christie, M. J. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00805.x · Cited by 65
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems
Viganò, D., Rubino, T., Vaccani, A., Bianchessi, S., Marmorato, P., Castiglioni, C., & Parolaro, D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0114-4 · Cited by 64
Endocannabinoids and basal ganglia functionality
Fernández‐Ruíz, J., Lastres‐Becker, I., Cabranes, A., González, S. R., & Ramos, J. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0350 · Cited by 65
Berrendero, F., Sánchez, A., Cabranes, A., Puerta, C., Ramos, J. A., García‐Merino, A., & Fernández‐Ruíz, J. (2001) · Synapse · doi:10.1002/syn.1075 · Cited by 65
Tadijan, A., Vlašić, I., Vlainić, J., Đikić, D., Oršolić, N., & Jembrek, M. J. (2022) · Antioxidants · doi:10.3390/antiox11102049 · Cited by 68
Wise, L. E., Long, K. A., Abdullah, R. A., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200130s · Cited by 66
Cannabinoids and glucocorticoids modulate emotional memory after stress
Akirav, I. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.08.002 · Cited by 65
Activation of G-proteins in brain by endogenous and exogenous cannabinoids
Childers, S. R. (2006) · The AAPS Journal · doi:10.1208/aapsj080113 · Cited by 64
Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia
Caballero, A. C., & Tseng, K. Y. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00101 · Cited by 63
Targeting the endocannabinoid system to treat anxiety-related disorders
Korem, N., Zer‐Aviv, T. M., Ganon-Elazar, E., Abush, H., & Akirav, I. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0058 · Cited by 69
Roles for the endocannabinoid system in ethanol-motivated behavior
Henderson, A. N., Guindon, J., & Morgan, D. J. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.011 · Cited by 63
Wiley, J. L. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00059-3 · Cited by 64
Fried, P. A. (1995) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-79451-3_21 · Cited by 64
Derkinderen, P., Siciliano, J. C., Toutant, M., & Girault, J. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00174.x · Cited by 63
Monhemius, R., Azami, J., Green, D. L., & Roberts, M. H. T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02605-1 · Cited by 64
Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice
Souilhac, J. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00396-z · Cited by 64
Sano, K., Mishima, K., Koushi, E., Orito, K., Egashira, N., Irie, K., Takasaki, K., Katsurabayashi, S., Iwasaki, K., Uchida, N., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.026 · Cited by 63
Maćkowiak, M., Chocyk, A., Dudys, D., & Wędzony, K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.037 · Cited by 65
Steiner, A. A., Molchanova, A. Y., Doğan, M. D., Patel, S., Pétervári, E., Balaskó, M., Wanner, S. P., Eales, J., de Oliveira, D. L., Gavva, N. R., et al. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.202465 · Cited by 63
A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord
Ong, W.-Y., & Mackie, K. (1999) · Journal of Neurocytology · doi:10.1023/a:1007011700677 · Cited by 63
Alvarez‐Jaimes, L., Polis, I. Y., & Parsons, L. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301630 · Cited by 64
CB1 cannabinoid receptor expression in brain regions associated with zebra finch song control
Soderstrom, K., & Johnson, F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02393-8 · Cited by 63
Alvares, D., & Fitzgerald, M. (1999) · Pain · doi:10.1016/s0304-3959(99)00140-2 · Cited by 63
The endocannabinoid system: a physiological perspective on its role in psychomotor control
Giuffrida, A., & Piomelli, D. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00193-6 · Cited by 63
Circadian rhythms and substance use disorders: A bidirectional relationship
Tamura, E. K., Silva, K. S. O., Ferreira-Moraes, F. A., Marinho, E. A. V., & Guerrero‐Vargas, N. N. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173105 · Cited by 67
Endocannabinoid signaling in social functioning: an RDoC perspective
Karhson, D. S., Hardan, A. Y., & Parker, K. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.169 · Cited by 62
Hill, M. N., Eiland, L. R., Lee, T. T.-Y., Hillard, C. J., & McEwen, B. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.036 · Cited by 65
Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD
Ney, L. J., Akhurst, J., Bruno, R., Laing, P. A. F., Matthews, A. J., & Felmingham, K. L. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110118 · Cited by 62
Effects of opioids, cannabinoids, and vanilloids on body temperature
Scott, M. R. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/190 · Cited by 62
Daniel, H., Rancillac, A., & Crépel, F. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063263 · Cited by 62
Maldonado, R. J., & Valverde, O. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.001 · Cited by 62
Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake
Verty, A. N. A., McFarlane, J. R., McGregor, I. S., & Mallet, P. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.002 · Cited by 62
Blair, R. E., Deshpande, L. S., Sombati, S., Elphick, M. R., Martin, B. R., & DeLorenzo, R. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.007 · Cited by 61
Schwitzer, T., Schwan, R., Angioï-Duprez, K., Ingster-Moati, I., Lalanne, L., Giersch, A., & Laprévote, V. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.002 · Cited by 66
Involvement of the endocannabinoid system in osteoarthritis pain
Porta, C. L., Bura, S. A., Negrete, R., & Maldonado, R. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12468 · Cited by 61
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
Moreira, F. A., de Aguiar, D. C., Campos, A. C., Lisboa, S. F. D. S., Terzian, A. L. B., Resstel, L. B. M., & Guimarães, F. S. (2008) · Neural Plasticity · doi:10.1155/2009/625469 · Cited by 62
Hegyi, Z., Kis, G., Holló, K., Ledent, C., & Antal, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06816.x · Cited by 66
Cannabinoid-induced Fos expression within A10 dopaminergic neurons
Patel, S., & Hillard, C. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03797-6 · Cited by 62
Navarro, M. A., de Miguel, R., de Fonseca, F. R., Ramos, J. A., & Fernández‐Ruíz, J. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00176-3 · Cited by 61
Median eminence nitric oxide signaling
Prévot, V., Bouret, S. G., Stefano, G. B., & Beauvillain, J. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00035-7 · Cited by 61
Kelly, R. L., Joers, V. L., Tansey, M. G., McKernan, D. P., & Dowd, E. (2020) · Molecules · doi:10.3390/molecules25030453 · Cited by 58
Leweke, F. M., Gerth, C. W., & tter, J. K. (2004) · CNS Drugs · doi:10.2165/00023210-200418130-00005 · Cited by 60
Robinson, R. H., Meissler, J. J., Deckman, J. M., Gaughan, J. P., Adler, M. W., & Eisenstein, T. K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9485-1 · Cited by 60
Therapeutic Potential of Endocannabinoid‐Hydrolysing Enzyme Inhibitors
Saario, S. M., & Laitinen, J. T. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00130.x · Cited by 60
HU 210: A Potent Tool for Investigations of the Cannabinoid System
Ottani, A., & Giuliani, D. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00192.x · Cited by 60
Chen, J.-Z., Han, X.-W., Liu, Q., Makriyannis, A., Wang, J., & Xie, X. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050655g · Cited by 60
Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 62
Therapeutic potential of cannabinoid receptor agonists as analgesic agents
Fox, A., & Bevan, S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.695 · Cited by 60
Garzón, J., de la Torre-Madrid, E., Rodríguez-Muñoz, M., Vicente‐Sánchez, A., & Sánchez‐Blázquez, P. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-11 · Cited by 60
Cannabinoids Excite Circadian Clock Neurons
Acuna, C., Obrietan, K. H., & van den Pol, A. N. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5838-09.2010 · Cited by 61
Cannabinoid modulation of peripheral autonomic and sensory neurotransmission
Ralevic, V. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01813-2 · Cited by 60
Lehmann, C., Kianian, M., Zhou, J., Küster, I., Kuschnereit, R., Whynot, S., Hung, O. R., Shukla, R., Johnston, B., Černý, V., et al. (2012) · Critical Care · doi:10.1186/cc11248 · Cited by 59
Hilário, M. R. F. (2008) · Frontiers in Neuroscience · doi:10.3389/neuro.01.030.2008 · Cited by 61
Ternianov, A., Pérez‐Ortiz, J. M., Solesio, M. E., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Navarrete, F., Leiva, C., Galindo, M. F., & Manzanares, J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.012 · Cited by 59
Bossong, M. G., Jansma, J. M., Bhattacharyya, S., & Ramsey, N. F. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 62
Hill, M. N., Froc, D. J., Fox, C. J., Gorzalka, B. B., & Christie, B. R. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03522.x · Cited by 59
CB1 Cannabinoid Receptor-Mediated Cell Migration
Song, Z.-H., & Zhong, M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39057-3 · Cited by 59
Romero, J., García‐Palomero, E., Lin, S., Ramos, J. A., Makriyannis, A., & Fernández‐Ruíz, J. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00086-0 · Cited by 59
Quality of Life and a Surveillant Endocannabinoid System
Reis, R. A. D. M., Isaac, A. R., Freitas, H. R., de Almeida, M. M., Schuck, P. F., Ferreira, G. C., Andrade‐da‐Costa, B. L. D. S., & Trevenzoli, I. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.747229 · Cited by 63
Membrane Phospholipids and Cytokine Interaction in Schizophrenia
Yao, J. K., & van Kammen, D. P. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59012-8 · Cited by 58
de Freitas, R. L., Salgado-Rohner, C. J., Hallak, J. E. C., Crippa, J. A. S., & Coimbra, N. C. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000163 · Cited by 57
Examining the roles of cannabinoids in pain and other therapeutic indications: a review
Turcotte, D., Dorze, J.-A. L., Esfahani, F., Frost, E. E., Gomori, A. J., & Namaka, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903413534 · Cited by 59
Hernández, M., Berrendero, F., Suárez, I., Garcı́a-Gil, L., Cebeira, M., Mackie, K., Ramos, J. A., & Fernández‐Ruíz, J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02322-7 · Cited by 58
Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats
Mendiguren, A., & Pineda, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.002 · Cited by 58
Engler, B., Freiman, I., Urbanski, M. J., & Szabó, B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092718 · Cited by 58
Egerton, A., Brett, R. R., & Pratt, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300715 · Cited by 57
Basavarajappa, B. S. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707781387920 · Cited by 57
Altered parahippocampal functioning in cannabis users is related to the frequency of use
Becker, B., Wagner, D. R., Gouzoulis‐Mayfrank, E., Spuentrup, E., & Daumann, J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1805-z · Cited by 58
Wegener, N., Kuhnert, S., Thüns, A., Roese, R., & Koch, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1148-1 · Cited by 57
Targeting the cannabinoid system for pain relief?
Chiou, L., Hu, S. S., & Ho, Y. (2013) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2013.10.004 · Cited by 59
Tudge, L., Williams, C., Cowen, P. J., & McCabe, C. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu094 · Cited by 57
Sphingosine‐1‐phosphate receptors mediate neuromodulatory functions in the CNS
Sim‐Selley, L. J., Goforth, P. B., Mba, U., Macdonald, T. L., Lynch, K. R., Milstien, S., Spiegel, S., Satin, L. S., Welch, S. P., & Selley, D. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06202.x · Cited by 57
Sidlo, Z., Reggio, P. H., & Rice, M. E. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.07.014 · Cited by 57
Pharmacological and therapeutic targets for Δ9 tetrahydrocannabinol and cannabidiol
Pertwee, R. G. (2004) · Euphytica · doi:10.1007/s10681-004-4756-9 · Cited by 57
GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons
Nyíri, G., Szabadits, E., Cserép, C., Mackie, K., Shigemoto, R., & Freund, T. F. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04146.x · Cited by 55
Endogenous cannabinoid ligands — chemical and biological studies
Mechoulam, R., Shabat, S., Hanus, L. O., Fride, E., Vogel, Z., Bayewitch, M. L., & Šulcová, A. (1996) · Journal of Lipid Mediators and Cell Signalling · doi:10.1016/0929-7855(96)01507-6 · Cited by 57
Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour
Ferrari, F., Ottani, A., & Giuliani, D. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00214-6 · Cited by 57
Endocannabinoid system in the adult rat circumventricular areas: An immunohistochemical study
Suárez, J., Romero‐Zerbo, S., Rivera, P., Bermúdez‐Silva, F. J., Pérez, J., de Fonseca, F. R., & Fernández‐Llebrez, P. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22382 · Cited by 57
Murray, E., Brouwer, S., McCutcheon, R. A., Harmer, C. J., Cowen, P. J., & McCabe, C. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3573-7 · Cited by 55
Hama, A. T., & Sagen, J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.031 · Cited by 56
Scherma, M., Muntoni, A. L., Melis, M., Fattore, L., Fadda, P., Fratta, W., & Pistis, M. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4196-3 · Cited by 59
Mechanisms of endocannabinoid transport in the brain
Kaczocha, M., & Haj‐Dahmane, S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15469 · Cited by 60
Metadata
- Authors
- Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Herkenham, M
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1991-02-01
- Volume
- 11
- Issue
- 2
- Pages
- 563-583
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6575215
- OpenAlex
- W1836729582
- Cited by
- 2,159
- References
- 65
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 43 · 2023: 56 · 2022: 64 · 2021: 65 · 2020: 84 · 2019: 61 · 2018: 74 · 2017: 70 · 2016: 70 · 2015: 95 · 2014: 77 · 2013: 74 · 2012: 86
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, receptor localization, receptor density, G protein coupling, enantioselectivity, basal ganglia, cerebellar molecular layer, olfactory bulb, hippocampus, substantia nigra pars reticulata, pituitary gland, rat brain
- MeSH terms
- Animals, Autoradiography, Brain, Buffers, Cannabinoids, Cyclohexanols, Male, Rats, Inbred Strains, Receptors, Drug, Serum Albumin, Bovine, Temperature, Time Factors, Tissue Distribution, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review